Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
With a market cap of 558.37B, Johnson & Johnson(JNJ) trades at $227.35. The stock has a price-to-earnings ratio of 26.15 and currently yields dividends of 2.3%.
On 2026-04-25, Johnson & Johnson(JNJ) stock traded between a low of $227.02 and a high of $229.99. Shares are currently priced at $227.35, which is +0.1% above the low and -1.1% below the high.
Johnson & Johnson(JNJ) shares are trading with a volume of 6.07M, against a daily average of 8.37M.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $251.71 and a 52-week low of $146.12.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $251.71 and a 52-week low of $146.12.
JNJ News
Earlier this week, Johnson & Johnson reported long-term Phase 3 Vivacity-MG3 and open-label extension data for IMAAVY (nipocalimab-aahu) in generalized myasthen...
These 5 Stocks Pay You Even When You’re Sleeping By Vandita Jadeja Published Apr 23, 4:04PM EDT Quick Read Johnson & Johnson (JNJ) raised its dividend for 64...
Johnson & Johnson (JNJ) shares set to snap six straight sessions of losses on Thursday, as the stock rose 1.9% to $230.42 in afternoon trading. The New Brunswi...
Analyst ratings
59%
of 29 ratingsMore JNJ News
Johnson & Johnson (NYSE:JNJ) reported new long-term clinical data for IMAAVY (nipocalimab-aahu) in generalized myasthenia gravis from the Phase 3 Vivacity-MG3 t...
Key Points Larger companies offer more stability but may offer less stock price appreciation. Smaller companies face more risk but may offer more upside than...
Johnson & Johnson announced new data from the Phase 3 Vivacity-MG3 study and ongoing open label extension, or OLE, in a broad population of antibody-positive, o...
Johnson & Johnson JNJ, via its Innovative Medicine segment, markets a broad portfolio of blockbuster therapies across key areas including neuroscience, cardiova...
Piper Sandler raised the firm’s price target on MeiraGTx (MGTX) to $30 from $26 and keeps an Overweight rating on the shares following the company’s long-term d...
Johnson & Johnson (JNJ) stock is drawing attention after recent trading left shares around $226.16, with a 1 day return of about a 2% decline and a past week mo...
GDV’s 6.1% Yield Faces a Hidden Test in 2026 Small-Cap Downturn By David Beren Published Apr 21, 3:34PM EDT Quick Read Gabelli Dividend & Income Trust (GDV) t...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.